Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity.

Rohm, Theresa V; Keller, Lena; Bosch, Angela J T; AlAsfoor, Shefaa; Baumann, Zora; Thomas, Amandine; Wiedemann, Sophia J; Steiger, Laura; Dalmas, Elise; Wehner, Josua; Rachid, Leila; Mooser, Catherine; Yilmaz, Bahtiyar; Fernandez Trigo, Nerea; Jauch, Annaise J; Wueest, Stephan; Konrad, Daniel; Henri, Sandrine; Niess, Jan H; Hruz, Petr; ... (2022). Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity. Communications biology, 5(1), p. 370. Springer Nature 10.1038/s42003-022-03305-z

[img]
Preview
Text
s42003-022-03305-z.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (4MB) | Preview

The obesity epidemic continues to worsen worldwide. However, the mechanisms initiating glucose dysregulation in obesity remain poorly understood. We assessed the role that colonic macrophage subpopulations play in glucose homeostasis in mice fed a high-fat diet (HFD). Concurrent with glucose intolerance, pro-inflammatory/monocyte-derived colonic macrophages increased in mice fed a HFD. A link between macrophage numbers and glycemia was established by pharmacological dose-dependent ablation of macrophages. In particular, colon-specific macrophage depletion by intrarectal clodronate liposomes improved glucose tolerance, insulin sensitivity, and insulin secretion capacity. Colonic macrophage activation upon HFD was characterized by an interferon response and a change in mitochondrial metabolism, which converged in mTOR as a common regulator. Colon-specific mTOR inhibition reduced pro-inflammatory macrophages and ameliorated insulin secretion capacity, similar to colon-specific macrophage depletion, but did not affect insulin sensitivity. Thus, pharmacological targeting of colonic macrophages could become a potential therapy in obesity to improve glycemic control.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie

UniBE Contributor:

Mooser, Catherine, Yilmaz, Bahtiyar (A), Fernandez Trigo, Nerea, Ganal-Vonarburg, Stephanie Christine

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2399-3642

Publisher:

Springer Nature

Language:

English

Submitter:

Pubmed Import

Date Deposited:

21 Apr 2022 15:21

Last Modified:

05 Dec 2022 16:19

Publisher DOI:

10.1038/s42003-022-03305-z

PubMed ID:

35440795

BORIS DOI:

10.48350/169418

URI:

https://boris.unibe.ch/id/eprint/169418

Actions (login required)

Edit item Edit item
Provide Feedback